Try our beta test site
2 studies found for:    SMAD3
Show Display Options
Rank Status Study
1 Recruiting First in Human Dose Escalation Study of TEW-7197 in Subjects With Advanced Stage Solid Tumors
Condition: Advanced Stage Solid Tumors
Intervention: Drug: TEW-7197
2 Not yet recruiting GLP-1 Receptor Agonist Therapy and Albuminuria in Patients With Type 2 Diabetes
Conditions: Type2 Diabetes;   Kidney Diseases
Interventions: Drug: Exenatide Extended Release for Inj Susp 2 MG;   Drug: Placebos

Study has passed its completion date and status has not been verified in more than two years.